Individualised Homeopathic Treatment of Acne—An Analysis of 83 PatientsFunding None.
Background Acne is a common disorder of the pilosebaceous follicle. The face, back and chest are usually involved. It leads to significant diminution in quality of life. Numerous treatments are documented in therapeutic guidelines. Naturopathic approaches have been proposed in some, but the role of homeopathy is not examined.
Methods In this study, 83 patients treated for acne with individualised homeopathic medicine alone were reviewed. Most had received conventional acne treatment, with limited success prior to presentation for homeopathy. Each patient was prescribed a single homeopathic medicine and followed up at 6- to 8-week intervals. The individualisation process resulted in 17 different medicines being used in this group. Photographic documentation was obtained per patient, with informed consent. Patients were classified as mild (comedonal acne with no papules or pustules), moderate (inflammatory and non-inflammatory lesions) and severe (predominantly inflammatory lesions: pustules, cysts, nodules). Results of treatment were recorded as remission (decrease in new lesion number, duration and intensity), failure to respond, and lost to follow-up (LTF).
Results The average age of patients was 21.5 years (range 11–45 years). The F:M ratio was 55 (66.3%):28 (33.7%). Average pre-treatment duration was 5.5 years (0.25–22 years). Seven (8.4%) patients had mild acne, 37 (44.6%) moderate, and 39 (47%) severe acne. There were 13 (15.7%) LTFs, two (2.4%) failed to respond, and 68 (81.9%) went into remission. Average time to remission was 1.9 months (range 1.5–6 months), with no relapses or side-effects. The most commonly prescribed medicines were Lycopodium (38.6%), Palladium (15.7%) and Platinum (12.1%).
Conclusion Individualised homeopathy may be useful for acne therapy. The most useful medicines appeared to be Lycopodium, Palladium and Platinum, though 17 different medicines were used in this study, underscoring the value of individualisation of therapy, a key characteristic of homeopathy.
This work was presented as e-poster P0051 at the European Academy of Dermatovenerology Congress, Vienna, 2016.
Eingereicht: 12. Dezember 2020
Angenommen: 01. März 2021
29. Juni 2021 (online)
© 2021. Faculty of Homeopathy. This article is published by Thieme.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 Wolkenstein P, Machovcová A, Szepietowski JC, Tennstedt D, Veraldi S, Delarue A. Acne prevalence and associations with lifestyle: a cross-sectional online survey of adolescents/young adults in 7 European countries. J Eur Acad Dermatol Venereol 2018; 32: 298-306
- 2 Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol 2013; 168: 474-485
- 3 Zaenglein AL, Pathy AL, Schlosser BJ. et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016; 74: 945-973
- 4 Hebert A, Thiboutot D, Gold LS. et al. Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: Two phase 3 randomized clinical trials. JAMA Dermatol 2020; 156: 621-630
- 5 Dossett ML, Davis RB, Kaptchuk TJ, Yeh GY. Homeopathy use by US adults: results of a national survey. Am J Public Health 2016; 106: 743-745
- 6 Winslow LS, Shapiro H. Physicians want education about complementary and alternative medicine to enhance communication with their patients. Arch Intern Med 2002; 162: 1176-1181
- 7 Sivamani RK, Morley JE, Rehal B, Armstrong AW. Comparative prevalence of complementary and alternative medicine use among outpatients in dermatology and primary care clinics. JAMA Dermatol 2014; 150: 1363-1365
- 8 Shraddhamayananda S. An observation on successful treatment of acne scar with homeopathic medicine. Int J Biopharmaceutics 2015; 6: 27-31
- 9 Nwabudike LC. Case reports of acne and homeopathy. Complement Med Res 2018; 25: 52-55
- 10 Miglani A, Manchanda RK. Observational study of Arctium lappa in the treatment of acne vulgaris. Homeopathy 2014; 103: 203-207
- 11 van Haselen RA. Homeopathic clinical case reports: Development of a supplement (HOM-CASE) to the CARE clinical case reporting guideline. Complement Ther Med 2016; 25: 78-85